India Neurodegenerative Disorder Therapeutics Market (2025-2031) | Segmentation, Size & Revenue, Share, Forecast, Analysis, Value, Trends, Competitive Landscape, Growth, Companies, Outlook, Industry

Market Forecast By Indication (Multiple sclerosis, Alzheimers Disease, Parkinsons Disease, Huntingtons Disease, Others), By Drug Glass (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Others), By Route of Administration (Oral, Injection, Transdermal), By End- User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And Competitive Landscape
Product Code: ETC7548797 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • India Neurodegenerative Disorder Therapeutics Market Outlook
  • Market Size of India Neurodegenerative Disorder Therapeutics Market, 2024
  • Forecast of India Neurodegenerative Disorder Therapeutics Market, 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Revenues & Volume for the Period 2021- 2031
  • India Neurodegenerative Disorder Therapeutics Market Trend Evolution
  • India Neurodegenerative Disorder Therapeutics Market Drivers and Challenges
  • India Neurodegenerative Disorder Therapeutics Price Trends
  • India Neurodegenerative Disorder Therapeutics Porter's Five Forces
  • India Neurodegenerative Disorder Therapeutics Industry Life Cycle
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Multiple sclerosis for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Alzheimers Disease for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Parkinsons Disease for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Huntingtons Disease for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Drug Glass for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Immunomodulator for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Interferons for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Decarboxylase Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Dopamine Agonists for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Injection for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Transdermal for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By End- User for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of India Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • India Neurodegenerative Disorder Therapeutics Import Export Trade Statistics
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Drug Glass
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End- User
  • India Neurodegenerative Disorder Therapeutics Top Companies Market Share
  • India Neurodegenerative Disorder Therapeutics Competitive Benchmarking By Technical and Operational Parameters
  • India Neurodegenerative Disorder Therapeutics Company Profiles
  • India Neurodegenerative Disorder Therapeutics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the India Neurodegenerative Disorder Therapeutics Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the India Neurodegenerative Disorder Therapeutics Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India Neurodegenerative Disorder Therapeutics Market Overview

3.1 India Country Macro Economic Indicators

3.2 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 India Neurodegenerative Disorder Therapeutics Market - Industry Life Cycle

3.4 India Neurodegenerative Disorder Therapeutics Market - Porter's Five Forces

3.5 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Drug Glass, 2021 & 2031F

3.7 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By End- User, 2021 & 2031F

4 India Neurodegenerative Disorder Therapeutics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Rising prevalence of neurodegenerative disorders in India

4.2.2 Increasing awareness and diagnosis of neurodegenerative disorders

4.2.3 Technological advancements in therapeutics for neurodegenerative disorders

4.3 Market Restraints

4.3.1 High cost of neurodegenerative disorder treatments

4.3.2 Limited access to specialized healthcare facilities in certain regions of India

4.3.3 Stringent regulatory requirements for drug approval and market entry

5 India Neurodegenerative Disorder Therapeutics Market Trends

6 India Neurodegenerative Disorder Therapeutics Market, By Types

6.1 India Neurodegenerative Disorder Therapeutics Market, By Indication

6.1.1 Overview and Analysis

6.1.2 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Multiple sclerosis, 2021- 2031F

6.1.4 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F

6.1.5 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F

6.1.6 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F

6.1.7 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.2 India Neurodegenerative Disorder Therapeutics Market, By Drug Glass

6.2.1 Overview and Analysis

6.2.2 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Immunomodulator, 2021- 2031F

6.2.3 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Interferons, 2021- 2031F

6.2.4 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Decarboxylase Inhibitors, 2021- 2031F

6.2.5 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.2.6 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.3 India Neurodegenerative Disorder Therapeutics Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Injection, 2021- 2031F

6.3.4 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Transdermal, 2021- 2031F

6.4 India Neurodegenerative Disorder Therapeutics Market, By End- User

6.4.1 Overview and Analysis

6.4.2 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.4.4 India Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7 India Neurodegenerative Disorder Therapeutics Market Import-Export Trade Statistics

7.1 India Neurodegenerative Disorder Therapeutics Market Export to Major Countries

7.2 India Neurodegenerative Disorder Therapeutics Market Imports from Major Countries

8 India Neurodegenerative Disorder Therapeutics Market Key Performance Indicators

8.1 Number of clinical trials for neurodegenerative disorder therapeutics in India

8.2 Adoption rate of novel therapies for neurodegenerative disorders

8.3 Investment in research and development of neurodegenerative disorder treatments

9 India Neurodegenerative Disorder Therapeutics Market - Opportunity Assessment

9.1 India Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 India Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Drug Glass, 2021 & 2031F

9.3 India Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 India Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By End- User, 2021 & 2031F

10 India Neurodegenerative Disorder Therapeutics Market - Competitive Landscape

10.1 India Neurodegenerative Disorder Therapeutics Market Revenue Share, By Companies, 2024

10.2 India Neurodegenerative Disorder Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All